Effect of Chiglitazar and Sitagliptin on Bone Mineral Density and Body Composition in Untreated Patients with Type 2 Diabetes.
Yuming WangYunting ZhouXiao ZhouXiaofei SuXiaohua XuHui-Qin LiJian-Hua MaPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2023)
The trial is registered at ClinicalTrials.gov (CT.gov identifier: NCT02173457).